Results 41 to 50 of about 17,825,014 (339)

Why and When Are Evidence‐Based Interventions Adopted in Paediatric Supportive Care? A Qualitative Exploration of the Determinants of Photobiomodulation Implementation

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Oral mucositis is a common and debilitating side effect of childhood cancer and stem cell transplant treatments. It affects the quality of life of children and young people (CYP) and places a strain on services. Photobiomodulation is recommended for oral mucositis prevention in international guidance but is poorly implemented in UK ...
Claudia Heggie, Kara A. Gray‐Burrows, Peter F. Day, Bob Phillips, Carl A. Thompson   +4 more
wiley   +1 more source

High-dose naloxone formulations are not as essential as we thought

Harm Reduction Journal
Naloxone is an effective FDA-approved opioid antagonist for reversing opioid overdoses. Naloxone is available to the public and can be administered through intramuscular (IM), intravenous (IV), and intranasal spray (IN) routes.
Paige M. Lemen, Daniel P. Garrett, Erin Thompson, Megan Aho, Christina Vasquez, Ju Nyeong Park   +5 more
doaj   +1 more source

Dexamethasone for Chemotherapy‐Induced Nausea and Vomiting Prevention in Pediatric Patients: International Consensus

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background An international Delphi panel of experts developed consensus statements to delineate the circumstances where the risks of dexamethasone as an antiemetic do and do not outweigh its benefits. Procedure Experts in supportive care of pediatric patients were invited to participate.
Negar Shavandi, Paula D. Robinson, Shana Jacobs, L. Lee Dupuis, the International Pediatric Dexamethasone Panel, Sameer Bakhshi, Tiene Bauters, Eva Brack, Simone Cesaro, Claire Fosbrook, Jason Freedman, Tamara MacDonald, Eloise Neumann, Venkatraman Radhakrishnan, Rod Rassekh, Florian Slimano, Johnathan Soggee, Joel Thompson, Marianne van de Wetering, Milena Villarroel, Jasper Wong   +20 more
wiley   +1 more source

Sustainability of opioid agonist therapy programmes in Belarus, the Republic of Moldova, Tajikistan and Ukraine in the context of transition from Global Fund support during 2020–2023

Harm Reduction Journal
Background Most national programmes of opioid agonist therapy (OAT) in Eastern Europe and Central Asia are at a critical juncture for building their sustainability due to decreasing support from the Global Fund and other international HIV funders ...
Raminta Stuikyte, Ivan Varentsov, Naimdzhon Malikov, Sergii Dvoriak, Myroslava Filippovych, Alisher Latypov, Aleksei Kralko, Ala Iatco, Catherine Cook   +8 more
doaj   +1 more source

Un-reduction

, 2011
This paper provides a full geometric development of a new technique called un-reduction, for dealing with dynamics and optimal control problems posed on spaces that are unwieldy for numerical implementation.
A. Clark, A. Kriegl, C. J. Cotter, C. J. Cotter, D. C. P. Ellis, D. C. P. Ellis, D. D. Holm, F. Gay-Balmaz, F. Gay-Balmaz, F.-X. Vialard, H. Cendra, H. Cendra, J. E. Marsden, J. E. Marsden, L. Younes, L. Younes, M. Bauer, P. W. Michor, P. W. Michor, P. W. Michor, R. Montgomery   +20 more
core   +3 more sources

Reduction in mobility and COVID-19 transmission

Nature Communications, 2021
In response to the COVID-19 pandemic, countries have sought to control SARS-CoV-2 transmission by restricting population movement through social distancing interventions, thus reducing the number of contacts.
P. Nouvellet, S. Bhatia, A. Cori, K. Ainslie, M. Baguelin, S. Bhatt, A. Boonyasiri, N. Brazeau, L. Cattarino, L. Cooper, H. Coupland, Z. Cucunubá, G. Cuomo-Dannenburg, A. Dighe, Bimandra A. Djaafara, I. Dorigatti, O. Eales, S. V. van Elsland, F. F. Nascimento, R. FitzJohn, K. Gaythorpe, L. Geidelberg, W. Green, A. Hamlet, K. Hauck, W. Hinsley, N. Imai, B. Jeffrey, E. Knock, D. Laydon, J. Lees, T. Mangal, T. Mellan, G. Nedjati-Gilani, K. Parag, M. Pons-Salort, M. Ragonnet-Cronin, S. Riley, H. Unwin, R. Verity, M. Vollmer, E. Volz, P. Walker, C. Walters, Haowei Wang, O. Watson, C. Whittaker, L. Whittles, X. Xi, N. Ferguson, C. Donnelly   +50 more
semanticscholar   +1 more source

Real‐World Pediatric Blinatumomab Administration: Access to Outpatient Care Delivery and Impact of a Hospital‐Dispensed Model

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Blinatumomab has been shown to be highly effective for patients with pediatric B‐ALL and has recently become standard of care therapy. Due to its past use in the clinical trial setting, there is limited information available about real‐world administration.
Katelyn Oranges, Kelly A. Duffy, Sara McDonough, Evelyn Kurpiewski, R. Jennifer Randall, Allison Barz Leahy, Haley M. Newman, Joyce P. Lee, Stephen P. Hunger, Anne F. Reilly, David T. Teachey, Susan R. Rheingold, Daniel J. Zheng   +12 more
wiley   +1 more source

Reduction [PDF]

, 2016
Reduction and reductionism have been central philosophical topics in analytic philosophy of science for more than six decades. Together they encompass a diversity of issues from metaphysics and epistemology.
Hüttemann, Andreas, Love, Alan
core  

On the Dimensional Reduction Procedure [PDF]

, 2000
The issue related to the so-called dimensional reduction procedure is revisited within the Euclidean formalism. First, it is shown that for symmetric spaces, the local exact heat-kernel density is equal to the reduced one, once the harmonic sum has been ...
Balbinot, Balbinot, Balbinot, Balbinot, Balbinot, Binosi, Bousso, Bytsenko, Bytsenko, Camporesi, Chiba, Cognola, DeWitt, Dowker, Elizalde, Elizalde, Elizalde, Elizalde, Elizalde, Frolov, Gates, Guido Cognola, Hawking, Iellici, Kummer, Kummer, Kummer, Lombardo, Mukhanov, Nojiri, Nojiri, Nojiri, Nojiri, Nojiri, Parker, Ray, Seeley, Sergio Zerbini, Sutton   +38 more
core   +3 more sources

Clinical Insights Into Hypercalcemia of Malignancy in Childhood

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Hypercalcemia of malignancy (HCM) is a rare but life‐threatening metabolic emergency in children that occurs in less than 1% of pediatric cancer cases, with a reported incidence ranging from 0.4% to 1.0% across different studies. While it is observed in 10%–20% of adult malignancies, pediatric HCM remains relatively uncommon.
Hüseyin Anıl Korkmaz
wiley   +1 more source